img

Global and United States Drug Discovery and Preclinical CRO Market Report & Forecast 2024-2034


Published on: 2024-01-04 | No of Pages : 400 | Industry : Software

Publisher : MRA | Format : PDF

Global and United States Drug Discovery and Preclinical CRO Market Report & Forecast 2024-2034

Market Analysis and InsightsGlobal and United States Drug Discovery and Preclinical CRO Market
This report focuses on global and United States Drug Discovery and Preclinical CRO market, also covers the segmentation data of other regions in regional level and county level.
The global Drug Discovery and Preclinical CRO revenue was US$ million in 2023 and is forecast to a readjusted size of US$ million by 2033 with a CAGR of % during the review period (2023-2033).
In United States the Drug Discovery and Preclinical CRO revenue is expected to grow from US$ million in 2023 to US$ million by 2033, at a CAGR of % during the forecast period 2023-2033.
The global key players of Drug Discovery and Preclinical CRO include Charles River, Wuxi AppTec, Labcorp, Eurofins Scientific, PPD, ICON plc, Pharmaron, Inotiv and ChemPartner, etc. The global five biggest players hold a share of % in 2023.
Global Drug Discovery and Preclinical CRO Scope and Market Size
Drug Discovery and Preclinical CRO market is segmented in regional and country level, by players, by Type and by Application. Companies, stakeholders, and other participants in the global Drug Discovery and Preclinical CRO market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application for the period 2018-2033.
For United States market, this report focuses on the Drug Discovery and Preclinical CRO market size by players, by Type and by Application, for the period 2018-2033. The key players include the global and local players, which play important roles in United States.



By Company


Charles River
Wuxi AppTec
Labcorp
Eurofins Scientific
PPD
ICON plc
Pharmaron
Inotiv
ChemPartner
JOINN Laboratories
Evotec
Medicilon
Crown Bioscience
Champions Oncology
Frontage Laboratories
Viva Biotech
Hitgen Inc.
Shanghai Innostar
Segment by Type
Drug Discovery
Preclinical Research

Segment by Application


Pharmaceutical Company
Biotech Company
Others
By Region
Americas
United States
Canada
Mexico
Brazil
China
APAC (excluding China)
Japan
South Korea
China Taiwan
ASEAN
India
EMEA
Europe
Middle East
Africa

Chapter Introduction


Chapter 1Introduces Drug Discovery and Preclinical CRO definition, global market size, United States market size, United States percentage in global market. This section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 2Provides the analysis of various market segments by type, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 3Provides the analysis of various market segments by application, covering the revenue and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 4Detailed analysis of Drug Discovery and Preclinical CRO companies’ competitive landscape, revenue, market share and industry ranking, latest development plan, merger and acquisition information, etc.
Chapter 5Revenue of Drug Discovery and Preclinical CRO in global and regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space of each country in the world.
Chapter 6Americas by type, by application and by country revenue for each segment.
Chapter 7EMEA by type, by application and by region, revenue for each segment.
Chapter 8China by type, by application revenue for each segment.
Chapter 9APAC (excluding China) by type, by application and by region, revenue for each segment.
Chapter 10Provides profiles of key companies, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Drug Discovery and Preclinical CRO revenue, gross margin and recent development, etc.
Chapter 11Analyst's Viewpoints/Conclusions

Table of Content

1 Study Coverage
1.1 Drug Discovery and Preclinical CRO Product Introduction
1.2 Global Drug Discovery and Preclinical CRO Outlook 2018 VS 2023 VS 2033
1.2.1 Global Drug Discovery and Preclinical CRO Market Size for the Year 2018-2033
1.2.2 United States Drug Discovery and Preclinical CRO Market Size for the Year 2018-2033
1.3 Drug Discovery and Preclinical CRO Market Size, United States VS Global, 2018 VS 2023 VS 2033
1.3.1 The Market Share of United States Drug Discovery and Preclinical CRO in Global, 2018 VS 2023 VS 2033
1.3.2 The Growth Rate of Drug Discovery and Preclinical CRO Market Size, United States VS Global, 2018 VS 2023 VS 2033
1.4 Drug Discovery and Preclinical CRO Market Dynamics
1.4.1 Drug Discovery and Preclinical CRO Industry Trends
1.4.2 Drug Discovery and Preclinical CRO Market Drivers
1.4.3 Drug Discovery and Preclinical CRO Market Challenges
1.4.4 Drug Discovery and Preclinical CRO Market Restraints
1.5 Assumptions and Limitations
1.6 Study Objectives
1.7 Years Considered
2 Drug Discovery and Preclinical CRO by Type
2.1 Drug Discovery and Preclinical CRO Market Segment by Type
2.1.1 Drug Discovery
2.1.2 Preclinical Research
2.2 Global Drug Discovery and Preclinical CRO Market Size by Type (2018, 2023 & 2033)
2.3 Global Drug Discovery and Preclinical CRO Market Size by Type (2018-2033)
2.4 United States Drug Discovery and Preclinical CRO Market Size by Type (2018, 2023 & 2033)
2.5 United States Drug Discovery and Preclinical CRO Market Size by Type (2018-2033)
3 Drug Discovery and Preclinical CRO by Application
3.1 Drug Discovery and Preclinical CRO Market Segment by Application
3.1.1 Pharmaceutical Company
3.1.2 Biotech Company
3.1.3 Others
3.2 Global Drug Discovery and Preclinical CRO Market Size by Application (2018, 2023 & 2033)
3.3 Global Drug Discovery and Preclinical CRO Market Size by Application (2018-2033)
3.4 United States Drug Discovery and Preclinical CRO Market Size by Application (2018, 2023 & 2033)
3.5 United States Drug Discovery and Preclinical CRO Market Size by Application (2018-2033)
4 Global Drug Discovery and Preclinical CRO Competitor Landscape by Company
4.1 Global Drug Discovery and Preclinical CRO Market Size by Company
4.1.1 Global Key Companies of Drug Discovery and Preclinical CRO, Ranked by Revenue (2023)
4.1.2 Global Drug Discovery and Preclinical CRO Revenue by Player (2018-2023)
4.2 Global Drug Discovery and Preclinical CRO Concentration Ratio (CR)
4.2.1 Drug Discovery and Preclinical CRO Market Concentration Ratio (CR) (2018-2023)
4.2.2 Global Top 5 and Top 10 Largest Companies of Drug Discovery and Preclinical CRO in 2023
4.2.3 Global Drug Discovery and Preclinical CRO Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
4.3 Global Key Players of Drug Discovery and Preclinical CRO Head office and Area Served
4.4 Global Key Players of Drug Discovery and Preclinical CRO, Product and Application
4.5 Global Key Players of Drug Discovery and Preclinical CRO, Date of Enter into This Industry
4.6 Companies Mergers & Acquisitions, Expansion Plans
4.7 United States Drug Discovery and Preclinical CRO Market Size by Company
4.7.1 Key Players of Drug Discovery and Preclinical CRO in United States, Ranked by Revenue (2023)
4.7.2 United States Drug Discovery and Preclinical CRO Revenue by Players (2021, 2023 & 2023)
5 Global Drug Discovery and Preclinical CRO Market Size by Region
5.1 Global Drug Discovery and Preclinical CRO Market Size by Region: 2018 VS 2023 VS 2033
5.2 Global Drug Discovery and Preclinical CRO Market Size by Region (2018-2033)
5.2.1 Global Drug Discovery and Preclinical CRO Market Size by Region: 2018-2023
5.2.2 Global Drug Discovery and Preclinical CRO Market Size by Region (2024-2033)
6 Americas
6.1 Americas Drug Discovery and Preclinical CRO Market Size YoY Growth 2018-2033
6.2 Americas Drug Discovery and Preclinical CRO Market Size by Type
6.2.1 Americas Drug Discovery and Preclinical CRO Market Size by Type (2018-2023)
6.2.2 Americas Drug Discovery and Preclinical CRO Market Size by Type (2024-2033)
6.2.3 Americas Drug Discovery and Preclinical CRO Market Share by Type (2018-2033)
6.3 Americas Drug Discovery and Preclinical CRO Market Size by Application
6.3.1 Americas Drug Discovery and Preclinical CRO Market Size by Application (2018-2023)
6.3.2 Americas Drug Discovery and Preclinical CRO Market Size by Application (2024-2033)
6.3.3 Americas Drug Discovery and Preclinical CRO Market Share by Application (2018-2033)
6.4 Americas Drug Discovery and Preclinical CRO Market Facts & Figures by Country (2018, 2023 & 2033)
6.4.1 United States
6.4.2 Canada
6.4.3 Mexico
6.4.4 Brazil
7 EMEA
7.1 EMEA Drug Discovery and Preclinical CRO Market Size YoY Growth 2018-2033
7.2 EMEA Drug Discovery and Preclinical CRO Market Size by Type
7.2.1 EMEA Drug Discovery and Preclinical CRO Market Size by Type (2018-2023)
7.2.2 EMEA Drug Discovery and Preclinical CRO Market Size by Type (2024-2033)
7.2.3 EMEA Drug Discovery and Preclinical CRO Market Share by Type (2018-2033)
7.3 EMEA Drug Discovery and Preclinical CRO Market Size by Application
7.3.1 EMEA Drug Discovery and Preclinical CRO Market Size by Application (2018-2023)
7.3.2 EMEA Drug Discovery and Preclinical CRO Market Size by Application (2024-2033)
7.3.3 EMEA Drug Discovery and Preclinical CRO Market Share by Application (2018-2033)
7.4 EMEA Drug Discovery and Preclinical CRO Market Facts & Figures by Country (2018, 2023 & 2033)
7.4.1 Europe
7.4.2 Middle East
7.4.3 Africa
8 China
8.1 China Drug Discovery and Preclinical CRO Market Size YoY Growth 2018-2033
8.2 China Drug Discovery and Preclinical CRO Market Size by Type
8.2.1 China Drug Discovery and Preclinical CRO Market Size by Type (2018-2023)
8.2.2 China Drug Discovery and Preclinical CRO Market Size by Type (2024-2033)
8.2.3 China Drug Discovery and Preclinical CRO Market Share by Type (2018-2033)
8.3 China Drug Discovery and Preclinical CRO Market Size by Application
8.3.1 China Drug Discovery and Preclinical CRO Market Size by Application (2018-2023)
8.3.2 China Drug Discovery and Preclinical CRO Market Size by Application (2024-2033)
8.3.3 China Drug Discovery and Preclinical CRO Market Share by Application (2018-2033)
9 APAC (excluding China)
9.1 APAC Drug Discovery and Preclinical CRO Market Size YoY Growth 2018-2033
9.2 APAC Drug Discovery and Preclinical CRO Market Size by Type
9.2.1 APAC Drug Discovery and Preclinical CRO Market Size by Type (2018-2023)
9.2.2 APAC Drug Discovery and Preclinical CRO Market Size by Type (2024-2033)
9.2.3 APAC Drug Discovery and Preclinical CRO Market Share by Type (2018-2033)
9.3 APAC Drug Discovery and Preclinical CRO Market Size by Application
9.3.1 APAC Drug Discovery and Preclinical CRO Market Size by Application (2018-2023)
9.3.2 APAC Drug Discovery and Preclinical CRO Market Size by Application (2024-2033)
9.3.3 APAC Drug Discovery and Preclinical CRO Market Share by Application (2018-2033)
9.4 APAC Drug Discovery and Preclinical CRO Market Facts & Figures by Country (2018, 2023 & 2033)
9.4.1 Japan
9.4.2 South Korea
9.4.3 China Taiwan
9.4.4 Southeast Asia
9.4.5 India
10 Key Players Profiles
10.1 Charles River
10.1.1 Charles River Company Details
10.1.2 Charles River Business Overview
10.1.3 Charles River Drug Discovery and Preclinical CRO Introduction
10.1.4 Charles River Revenue in Drug Discovery and Preclinical CRO Business (2018-2023)
10.1.5 Charles River Recent Development
10.2 Wuxi AppTec
10.2.1 Wuxi AppTec Company Details
10.2.2 Wuxi AppTec Business Overview
10.2.3 Wuxi AppTec Drug Discovery and Preclinical CRO Introduction
10.2.4 Wuxi AppTec Revenue in Drug Discovery and Preclinical CRO Business (2018-2023)
10.2.5 Wuxi AppTec Recent Development
10.3 Labcorp
10.3.1 Labcorp Company Details
10.3.2 Labcorp Business Overview
10.3.3 Labcorp Drug Discovery and Preclinical CRO Introduction
10.3.4 Labcorp Revenue in Drug Discovery and Preclinical CRO Business (2018-2023)
10.3.5 Labcorp Recent Development
10.4 Eurofins Scientific
10.4.1 Eurofins Scientific Company Details
10.4.2 Eurofins Scientific Business Overview
10.4.3 Eurofins Scientific Drug Discovery and Preclinical CRO Introduction
10.4.4 Eurofins Scientific Revenue in Drug Discovery and Preclinical CRO Business (2018-2023)
10.4.5 Eurofins Scientific Recent Development
10.5 PPD
10.5.1 PPD Company Details
10.5.2 PPD Business Overview
10.5.3 PPD Drug Discovery and Preclinical CRO Introduction
10.5.4 PPD Revenue in Drug Discovery and Preclinical CRO Business (2018-2023)
10.5.5 PPD Recent Development
10.6 ICON plc
10.6.1 ICON plc Company Details
10.6.2 ICON plc Business Overview
10.6.3 ICON plc Drug Discovery and Preclinical CRO Introduction
10.6.4 ICON plc Revenue in Drug Discovery and Preclinical CRO Business (2018-2023)
10.6.5 ICON plc Recent Development
10.7 Pharmaron
10.7.1 Pharmaron Company Details
10.7.2 Pharmaron Business Overview
10.7.3 Pharmaron Drug Discovery and Preclinical CRO Introduction
10.7.4 Pharmaron Revenue in Drug Discovery and Preclinical CRO Business (2018-2023)
10.7.5 Pharmaron Recent Development
10.8 Inotiv
10.8.1 Inotiv Company Details
10.8.2 Inotiv Business Overview
10.8.3 Inotiv Drug Discovery and Preclinical CRO Introduction
10.8.4 Inotiv Revenue in Drug Discovery and Preclinical CRO Business (2018-2023)
10.8.5 Inotiv Recent Development
10.9 ChemPartner
10.9.1 ChemPartner Company Details
10.9.2 ChemPartner Business Overview
10.9.3 ChemPartner Drug Discovery and Preclinical CRO Introduction
10.9.4 ChemPartner Revenue in Drug Discovery and Preclinical CRO Business (2018-2023)
10.9.5 ChemPartner Recent Development
10.10 JOINN Laboratories
10.10.1 JOINN Laboratories Company Details
10.10.2 JOINN Laboratories Business Overview
10.10.3 JOINN Laboratories Drug Discovery and Preclinical CRO Introduction
10.10.4 JOINN Laboratories Revenue in Drug Discovery and Preclinical CRO Business (2018-2023)
10.10.5 JOINN Laboratories Recent Development
10.11 Evotec
10.11.1 Evotec Company Details
10.11.2 Evotec Business Overview
10.11.3 Evotec Drug Discovery and Preclinical CRO Introduction
10.11.4 Evotec Revenue in Drug Discovery and Preclinical CRO Business (2018-2023)
10.11.5 Evotec Recent Development
10.12 Medicilon
10.12.1 Medicilon Company Details
10.12.2 Medicilon Business Overview
10.12.3 Medicilon Drug Discovery and Preclinical CRO Introduction
10.12.4 Medicilon Revenue in Drug Discovery and Preclinical CRO Business (2018-2023)
10.12.5 Medicilon Recent Development
10.13 Crown Bioscience
10.13.1 Crown Bioscience Company Details
10.13.2 Crown Bioscience Business Overview
10.13.3 Crown Bioscience Drug Discovery and Preclinical CRO Introduction
10.13.4 Crown Bioscience Revenue in Drug Discovery and Preclinical CRO Business (2018-2023)
10.13.5 Crown Bioscience Recent Development
10.14 Champions Oncology
10.14.1 Champions Oncology Company Details
10.14.2 Champions Oncology Business Overview
10.14.3 Champions Oncology Drug Discovery and Preclinical CRO Introduction
10.14.4 Champions Oncology Revenue in Drug Discovery and Preclinical CRO Business (2018-2023)
10.14.5 Champions Oncology Recent Development
10.15 Frontage Laboratories
10.15.1 Frontage Laboratories Company Details
10.15.2 Frontage Laboratories Business Overview
10.15.3 Frontage Laboratories Drug Discovery and Preclinical CRO Introduction
10.15.4 Frontage Laboratories Revenue in Drug Discovery and Preclinical CRO Business (2018-2023)
10.15.5 Frontage Laboratories Recent Development
10.16 Viva Biotech
10.16.1 Viva Biotech Company Details
10.16.2 Viva Biotech Business Overview
10.16.3 Viva Biotech Drug Discovery and Preclinical CRO Introduction
10.16.4 Viva Biotech Revenue in Drug Discovery and Preclinical CRO Business (2018-2023)
10.16.5 Viva Biotech Recent Development
10.17 Hitgen Inc.
10.17.1 Hitgen Inc. Company Details
10.17.2 Hitgen Inc. Business Overview
10.17.3 Hitgen Inc. Drug Discovery and Preclinical CRO Introduction
10.17.4 Hitgen Inc. Revenue in Drug Discovery and Preclinical CRO Business (2018-2023)
10.17.5 Hitgen Inc. Recent Development
10.18 Shanghai Innostar
10.18.1 Shanghai Innostar Company Details
10.18.2 Shanghai Innostar Business Overview
10.18.3 Shanghai Innostar Drug Discovery and Preclinical CRO Introduction
10.18.4 Shanghai Innostar Revenue in Drug Discovery and Preclinical CRO Business (2018-2023)
10.18.5 Shanghai Innostar Recent Development
11 Research Findings and Conclusion
12 Appendix
12.1 Research Methodology
12.1.1 Methodology/Research Approach
12.1.2 Data Source
12.2 Disclaimer
12.3 Author Details

List of Figure

List of Tables
Table 1. Drug Discovery and Preclinical CRO Market Size United States VS Global, CAGR (2018 VS 2023 VS 2033)
Table 2. Drug Discovery and Preclinical CRO Market Trends
Table 3. Drug Discovery and Preclinical CRO Market Drivers
Table 4. Drug Discovery and Preclinical CRO Market Challenges
Table 5. Drug Discovery and Preclinical CRO Market Restraints
Table 6. Global Drug Discovery and Preclinical CRO Market Size by Type: 2018 VS 2023 VS 2033 (US$ Million)
Table 7. United States Drug Discovery and Preclinical CRO Market Size by Type: 2018 VS 2023 VS 2033 (US$ Million)
Table 8. Global Drug Discovery and Preclinical CRO Market Size by Application: 2018 VS 2023 VS 2033 (US$ Million)
Table 9. United States Drug Discovery and Preclinical CRO Market Size by Application: 2018 VS 2023 VS 2033 (US$ Million)
Table 10. Global Key Companies of Drug Discovery and Preclinical CRO, Ranked by Revenue (2023) & (US$ Million)
Table 11. Global Drug Discovery and Preclinical CRO Revenue by Player, (US$ Million), 2018-2023
Table 12. Global Drug Discovery and Preclinical CRO Revenue Share by Player, 2018-2023
Table 13. Global Drug Discovery and Preclinical CRO Companies Market Concentration Ratio (CR5 and HHI)
Table 14. Global Drug Discovery and Preclinical CRO by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Drug Discovery and Preclinical CRO as of 2023)
Table 15. Global Key Players of Drug Discovery and Preclinical CRO, Headquarters and Area Served
Table 16. Global Key Players of Drug Discovery and Preclinical CRO, Product and Application
Table 17. Global Key Players of Drug Discovery and Preclinical CRO, Date of Enter into This Industry
Table 18. Companies Mergers & Acquisitions, Expansion Plans
Table 19. Key Players of Drug Discovery and Preclinical CRO in United States, Ranked by Revenue (2023) & (US$ Million)
Table 20. United States Drug Discovery and Preclinical CRO Revenue by Players, (US$ Million), 2021, 2023 & 2023
Table 21. United States Drug Discovery and Preclinical CRO Revenue Share by Players, 2021, 2023 & 2023
Table 22. Global Drug Discovery and Preclinical CRO Market Size Growth Rate (CAGR) by Region (US$ Million): 2018 VS 2023 VS 2033
Table 23. Global Drug Discovery and Preclinical CRO Market Size by Region (2018-2023) & (US$ Million)
Table 24. Global Drug Discovery and Preclinical CRO Market Size Forecast by Region (2024-2033) & (US$ Million)
Table 25. Americas Drug Discovery and Preclinical CRO Market Size by Type (2018-2023) & (US$ Million)
Table 26. Americas Drug Discovery and Preclinical CRO Market Size by Type (2024-2033) & (US$ Million)
Table 27. Americas Drug Discovery and Preclinical CRO Market Size by Application (2018-2023) & (US$ Million)
Table 28. Americas Drug Discovery and Preclinical CRO Market Size by Application (2024-2033) & (US$ Million)
Table 29. Americas Drug Discovery and Preclinical CRO Market Size Growth Rate (CAGR) by Country (US$ Million): 2018 VS 2023 VS 2033
Table 30. Americas Drug Discovery and Preclinical CRO Market Size by Country (2018-2023) & (US$ Million)
Table 31. Americas Drug Discovery and Preclinical CRO Market Size by Country (2024-2033) & (US$ Million)
Table 32. EMEA Drug Discovery and Preclinical CRO Market Size by Type (2018-2023) & (US$ Million)
Table 33. EMEA Drug Discovery and Preclinical CRO Market Size by Type (2024-2033) & (US$ Million)
Table 34. EMEA Drug Discovery and Preclinical CRO Market Size by Application (2018-2023) & (US$ Million)
Table 35. EMEA Drug Discovery and Preclinical CRO Market Size by Application (2024-2033) & (US$ Million)
Table 36. EMEA Drug Discovery and Preclinical CRO Market Size Growth Rate (CAGR) by Country (US$ Million): 2018 VS 2023 VS 2033
Table 37. EMEA Drug Discovery and Preclinical CRO Market Size by Country (2018-2023) & (US$ Million)
Table 38. EMEA Drug Discovery and Preclinical CRO Market Size by Country (2024-2033) & (US$ Million)
Table 39. China Drug Discovery and Preclinical CRO Market Size by Type (2018-2023) & (US$ Million)
Table 40. China Drug Discovery and Preclinical CRO Market Size by Type (2024-2033) & (US$ Million)
Table 41. China Drug Discovery and Preclinical CRO Market Size by Application (2018-2023) & (US$ Million)
Table 42. China Drug Discovery and Preclinical CRO Market Size by Application (2024-2033) & (US$ Million)
Table 43. China Drug Discovery and Preclinical CRO Market Size Growth Rate (CAGR) by Country (US$ Million): 2018 VS 2023 VS 2033
Table 44. APAC Drug Discovery and Preclinical CRO Market Size by Type (2018-2023) & (US$ Million)
Table 45. APAC Drug Discovery and Preclinical CRO Market Size by Type (2024-2033) & (US$ Million)
Table 46. APAC Drug Discovery and Preclinical CRO Market Size by Application (2018-2023) & (US$ Million)
Table 47. APAC Drug Discovery and Preclinical CRO Market Size by Application (2024-2033) & (US$ Million)
Table 48. APAC Drug Discovery and Preclinical CRO Market Size Growth Rate (CAGR) by Country (US$ Million): 2018 VS 2023 VS 2033
Table 49. APAC Drug Discovery and Preclinical CRO Market Size by Region (2018-2023) & (US$ Million)
Table 50. APAC Drug Discovery and Preclinical CRO Market Size by Region (2024-2033) & (US$ Million)
Table 51. Charles River Company Details
Table 52. Charles River Business Overview
Table 53. Charles River Drug Discovery and Preclinical CRO Product
Table 54. Charles River Revenue in Drug Discovery and Preclinical CRO Business (2018-2023) & (US$ Million)
Table 55. Charles River Recent Development
Table 56. Wuxi AppTec Company Details
Table 57. Wuxi AppTec Business Overview
Table 58. Wuxi AppTec Drug Discovery and Preclinical CRO Product
Table 59. Wuxi AppTec Revenue in Drug Discovery and Preclinical CRO Business (2018-2023) & (US$ Million)
Table 60. Wuxi AppTec Recent Development
Table 61. Labcorp Company Details
Table 62. Labcorp Business Overview
Table 63. Labcorp Drug Discovery and Preclinical CRO Product
Table 64. Labcorp Revenue in Drug Discovery and Preclinical CRO Business (2018-2023) & (US$ Million)
Table 65. Labcorp Recent Development
Table 66. Eurofins Scientific Company Details
Table 67. Eurofins Scientific Business Overview
Table 68. Eurofins Scientific Drug Discovery and Preclinical CRO Product
Table 69. Eurofins Scientific Revenue in Drug Discovery and Preclinical CRO Business (2018-2023) & (US$ Million)
Table 70. Eurofins Scientific Recent Development
Table 71. PPD Company Details
Table 72. PPD Business Overview
Table 73. PPD Drug Discovery and Preclinical CRO Product
Table 74. PPD Revenue in Drug Discovery and Preclinical CRO Business (2018-2023) & (US$ Million)
Table 75. PPD Recent Development
Table 76. ICON plc Company Details
Table 77. ICON plc Business Overview
Table 78. ICON plc Drug Discovery and Preclinical CRO Product
Table 79. ICON plc Revenue in Drug Discovery and Preclinical CRO Business (2018-2023) & (US$ Million)
Table 80. ICON plc Recent Development
Table 81. Pharmaron Company Details
Table 82. Pharmaron Business Overview
Table 83. Pharmaron Drug Discovery and Preclinical CRO Product
Table 84. Pharmaron Revenue in Drug Discovery and Preclinical CRO Business (2018-2023) & (US$ Million)
Table 85. Pharmaron Recent Development
Table 86. Inotiv Company Details
Table 87. Inotiv Business Overview
Table 88. Inotiv Drug Discovery and Preclinical CRO Product
Table 89. Inotiv Revenue in Drug Discovery and Preclinical CRO Business (2018-2023) & (US$ Million)
Table 90. Inotiv Recent Development
Table 91. ChemPartner Company Details
Table 92. ChemPartner Business Overview
Table 93. ChemPartner Drug Discovery and Preclinical CRO Product
Table 94. ChemPartner Revenue in Drug Discovery and Preclinical CRO Business (2018-2023) & (US$ Million)
Table 95. ChemPartner Recent Development
Table 96. JOINN Laboratories Company Details
Table 97. JOINN Laboratories Business Overview
Table 98. JOINN Laboratories Drug Discovery and Preclinical CRO Product
Table 99. JOINN Laboratories Revenue in Drug Discovery and Preclinical CRO Business (2018-2023) & (US$ Million)
Table 100. JOINN Laboratories Recent Development
Table 101. Evotec Company Details
Table 102. Evotec Business Overview
Table 103. Evotec Drug Discovery and Preclinical CRO Product
Table 104. Evotec Revenue in Drug Discovery and Preclinical CRO Business (2018-2023) & (US$ Million)
Table 105. Evotec Recent Development
Table 106. Medicilon Company Details
Table 107. Medicilon Business Overview
Table 108. Medicilon Drug Discovery and Preclinical CRO Product
Table 109. Medicilon Revenue in Drug Discovery and Preclinical CRO Business (2018-2023) & (US$ Million)
Table 110. Medicilon Recent Development
Table 111. Crown Bioscience Company Details
Table 112. Crown Bioscience Business Overview
Table 113. Crown Bioscience Drug Discovery and Preclinical CRO Product
Table 114. Crown Bioscience Revenue in Drug Discovery and Preclinical CRO Business (2018-2023) & (US$ Million)
Table 115. Crown Bioscience Recent Development
Table 116. Champions Oncology Company Details
Table 117. Champions Oncology Business Overview
Table 118. Champions Oncology Drug Discovery and Preclinical CRO Product
Table 119. Champions Oncology Revenue in Drug Discovery and Preclinical CRO Business (2018-2023) & (US$ Million)
Table 120. Champions Oncology Recent Development
Table 121. Frontage Laboratories Company Details
Table 122. Frontage Laboratories Business Overview
Table 123. Frontage Laboratories Drug Discovery and Preclinical CRO Product
Table 124. Frontage Laboratories Revenue in Drug Discovery and Preclinical CRO Business (2018-2023) & (US$ Million)
Table 125. Frontage Laboratories Recent Development
Table 126. Viva Biotech Company Details
Table 127. Viva Biotech Business Overview
Table 128. Viva Biotech Drug Discovery and Preclinical CRO Product
Table 129. Viva Biotech Revenue in Drug Discovery and Preclinical CRO Business (2018-2023) & (US$ Million)
Table 130. Viva Biotech Recent Development
Table 131. Hitgen Inc. Company Details
Table 132. Hitgen Inc. Business Overview
Table 133. Hitgen Inc. Drug Discovery and Preclinical CRO Product
Table 134. Hitgen Inc. Revenue in Drug Discovery and Preclinical CRO Business (2018-2023) & (US$ Million)
Table 135. Hitgen Inc. Recent Development
Table 136. Shanghai Innostar Company Details
Table 137. Shanghai Innostar Business Overview
Table 138. Shanghai Innostar Drug Discovery and Preclinical CRO Product
Table 139. Shanghai Innostar Revenue in Drug Discovery and Preclinical CRO Business (2018-2023) & (US$ Million)
Table 140. Shanghai Innostar Recent Development
Table 141. Research Programs/Design for This Report
Table 142. Key Data Information from Secondary Sources
Table 143. Key Data Information from Primary Sources
List of Figures
Figure 1. Drug Discovery and Preclinical CRO Product Picture
Figure 2. Global Drug Discovery and Preclinical CRO Market Size, (US$ Million), 2018 VS 2023 VS 2033
Figure 3. Global Drug Discovery and Preclinical CRO Market Size 2018-2033 (US$ Million)
Figure 4. United States Drug Discovery and Preclinical CRO Market Size, (US$ Million), 2018 VS 2023 VS 2033
Figure 5. United States Drug Discovery and Preclinical CRO Market Size 2018-2033 (US$ Million)
Figure 6. United States Drug Discovery and Preclinical CRO Market Share in Global 2018-2033
Figure 7. Drug Discovery and Preclinical CRO Report Years Considered
Figure 8. Product Picture of Drug Discovery
Figure 9. Product Picture of Preclinical Research
Figure 10. Global Drug Discovery and Preclinical CRO Market Share by Type in 2023 & 2033
Figure 11. Global Drug Discovery and Preclinical CRO Market Size by Type (2018-2033) & (US$ Million)
Figure 12. Global Drug Discovery and Preclinical CRO Market Share by Type (2018-2033)
Figure 13. United States Drug Discovery and Preclinical CRO Market Share by Type in 2023 & 2033
Figure 14. United States Drug Discovery and Preclinical CRO Market Size by Type (2018-2033) & (US$ Million)
Figure 15. United States Drug Discovery and Preclinical CRO Market Share by Type (2018-2033)
Figure 16. Product Picture of Pharmaceutical Company
Figure 17. Product Picture of Biotech Company
Figure 18. Product Picture of Others
Figure 19. Global Drug Discovery and Preclinical CRO Market Share by Application in 2023 & 2033
Figure 20. Global Drug Discovery and Preclinical CRO Market Size by Application (2018-2033) & (US$ Million)
Figure 21. Global Drug Discovery and Preclinical CRO Market Share by Application (2018-2033)
Figure 22. United States Drug Discovery and Preclinical CRO Market Share by Application in 2023 & 2033
Figure 23. United States Drug Discovery and Preclinical CRO Market Size by Application (2018-2033) & (US$ Million)
Figure 24. United States Drug Discovery and Preclinical CRO Market Share by Application (2018-2033)
Figure 25. The Top 5 and 10 Largest Companies of Drug Discovery and Preclinical CRO in the World: Market Share by Drug Discovery and Preclinical CRO Revenue in 2023
Figure 26. Global Drug Discovery and Preclinical CRO Market Size Market Share by Region: 2018 VS 2023 VS 2033
Figure 27. Global Drug Discovery and Preclinical CRO Market Share by Region (2018-2033)
Figure 28. Americas Drug Discovery and Preclinical CRO Market Size Growth Rate 2018-2033 (US$ Million)
Figure 29. Americas Drug Discovery and Preclinical CRO Market Share by Type (2018-2033)
Figure 30. Americas Drug Discovery and Preclinical CRO Market Share by Application (2018-2033)
Figure 31. United States Drug Discovery and Preclinical CRO Market Size Growth Rate (2018-2033) & (US$ Million)
Figure 32. Canada Drug Discovery and Preclinical CRO Market Size Growth Rate (2018-2033) & (US$ Million)
Figure 33. Mexico Drug Discovery and Preclinical CRO Market Size Growth Rate (2018-2033) & (US$ Million)
Figure 34. Brazil Drug Discovery and Preclinical CRO Market Size Growth Rate (2018-2033) & (US$ Million)
Figure 35. EMEA Drug Discovery and Preclinical CRO Market Size Growth Rate 2018-2033 (US$ Million)
Figure 36. EMEA Drug Discovery and Preclinical CRO Market Share by Type (2018-2033)
Figure 37. EMEA Drug Discovery and Preclinical CRO Market Share by Application (2018-2033)
Figure 38. Europe Drug Discovery and Preclinical CRO Market Size Growth Rate (2018-2033) & (US$ Million)
Figure 39. Middle East Drug Discovery and Preclinical CRO Market Size Growth Rate (2018-2033) & (US$ Million)
Figure 40. Africa Drug Discovery and Preclinical CRO Market Size Growth Rate (2018-2033) & (US$ Million)
Figure 41. China Drug Discovery and Preclinical CRO Market Size Growth Rate 2018-2033 (US$ Million)
Figure 42. China Drug Discovery and Preclinical CRO Market Share by Type (2018-2033)
Figure 43. China Drug Discovery and Preclinical CRO Market Share by Application (2018-2033)
Figure 44. APAC Drug Discovery and Preclinical CRO Market Size Growth Rate 2018-2033 (US$ Million)
Figure 45. APAC Drug Discovery and Preclinical CRO Market Share by Type (2018-2033)
Figure 46. APAC Drug Discovery and Preclinical CRO Market Share by Application (2018-2033)
Figure 47. Japan Drug Discovery and Preclinical CRO Market Size Growth Rate (2018-2033) & (US$ Million)
Figure 48. South Korea Drug Discovery and Preclinical CRO Market Size Growth Rate (2018-2033) & (US$ Million)
Figure 49. China Taiwan Drug Discovery and Preclinical CRO Market Size Growth Rate (2018-2033) & (US$ Million)
Figure 50. Southeast Asia Drug Discovery and Preclinical CRO Market Size Growth Rate (2018-2033) & (US$ Million)
Figure 51. India Drug Discovery and Preclinical CRO Market Size Growth Rate (2018-2033) & (US$ Million)
Figure 52. Charles River Revenue Growth Rate in Drug Discovery and Preclinical CRO Business (2018-2023)
Figure 53. Wuxi AppTec Revenue Growth Rate in Drug Discovery and Preclinical CRO Business (2018-2023)
Figure 54. Labcorp Revenue Growth Rate in Drug Discovery and Preclinical CRO Business (2018-2023)
Figure 55. Eurofins Scientific Revenue Growth Rate in Drug Discovery and Preclinical CRO Business (2018-2023)
Figure 56. PPD Revenue Growth Rate in Drug Discovery and Preclinical CRO Business (2018-2023)
Figure 57. ICON plc Revenue Growth Rate in Drug Discovery and Preclinical CRO Business (2018-2023)
Figure 58. Pharmaron Revenue Growth Rate in Drug Discovery and Preclinical CRO Business (2018-2023)
Figure 59. Inotiv Revenue Growth Rate in Drug Discovery and Preclinical CRO Business (2018-2023)
Figure 60. ChemPartner Revenue Growth Rate in Drug Discovery and Preclinical CRO Business (2018-2023)
Figure 61. JOINN Laboratories Revenue Growth Rate in Drug Discovery and Preclinical CRO Business (2018-2023)
Figure 62. Evotec Revenue Growth Rate in Drug Discovery and Preclinical CRO Business (2018-2023)
Figure 63. Medicilon Revenue Growth Rate in Drug Discovery and Preclinical CRO Business (2018-2023)
Figure 64. Crown Bioscience Revenue Growth Rate in Drug Discovery and Preclinical CRO Business (2018-2023)
Figure 65. Champions Oncology Revenue Growth Rate in Drug Discovery and Preclinical CRO Business (2018-2023)
Figure 66. Frontage Laboratories Revenue Growth Rate in Drug Discovery and Preclinical CRO Business (2018-2023)
Figure 67. Viva Biotech Revenue Growth Rate in Drug Discovery and Preclinical CRO Business (2018-2023)
Figure 68. Hitgen Inc. Revenue Growth Rate in Drug Discovery and Preclinical CRO Business (2018-2023)
Figure 69. Shanghai Innostar Revenue Growth Rate in Drug Discovery and Preclinical CRO Business (2018-2023)
Figure 70. Bottom-up and Top-down Approaches for This Report
Figure 71. Data Triangulation
Figure 72. Key Executives Interviewed